Stem cells: Applications in
regenerative medicine
Dr. Bhavika
PG-1
Department of Biochemistry
Introduction
• Stem cells are undifferentiated cells
with the remarkable potential to
develop into different types of cells in
the body during early life and growth.
• They have importance in medical
research and treatment due to their
ability to regenerate and repair
damaged tissues and organs.
• Provide a foundation for studying
developmental processes, disease
modeling, and drug testing.
Types of stem cells
Type of Stem Cells Characteristics Potential Applications
Study development, disease
Derived from embryos typically modeling, potential therapies for
Embryonic Stem Cells 5-7 days old various diseases
Adult Stem Cells (Somatic or Found in specific tissues (e.g., Repair and replenish damaged
Tissue-specific) bone marrow, brain, skin) cells in their tissue of origin, used
in some therapies
Induced Pluripotent Stem Cells Adult cells reprogrammed to Disease modeling, drug
(iPSCs) have pluripotent capabilities screening, potential therapies
Perinatal Stem Cells Found in amniotic fluid, umbilical Potential alternative to
cord blood and tissue embryonic stem cells,
regenerative therapies
Embryonic Stem Cells
• Pluripotent: Can differentiate into
cells of all three germ layers
(endoderm, mesoderm, and
ectoderm).
• Self-renewal: Can divide and replicate
indefinitely.
• Derived from blastocysts: Typically
obtained from excess embryos from
fertility clinics.
• High potential for differentiation into
various cell types.
Adult Stem Cells
• Multipotent or Unipotent:
Can differentiate into a
limited number of cell types
related to their tissue of
origin.
• Self-renewal
• Found in Adult Tissues: bone
marrow (hematopoietic stem
cells), brain (neural stem
cells), skin (epidermal stem
cells).
Adult Stem Cells
Potential Applications
• Regenerative Medicine: Used in therapies to repair or replace
damaged tissues and organs, such as bone marrow transplants for
blood disorders.
• Tissue Engineering: Used to grow tissues or organs in the lab for
transplantation.
• Research: Provide insights into tissue development, aging, and
diseases.
Induced Pluripotent Stem Cells
• Artificially derived from adult cells,
typically skin or blood cells, through
reprogramming.
• Reprogramming involves introducing
specific genes into these adult cells,
which resets their state to that of
embryonic-like pluripotent stem cells.
Induced Pluripotent Stem Cells
• Disease Modeling: iPSCs can be generated from patients with genetic diseases,
providing a platform to study disease mechanisms and develop personalized
therapies.
• Drug Screening: Used to test potential drugs for safety and efficacy in a more
relevant human cell model.
• Regenerative Medicine: iPSCs hold promise for developing patient-specific cell
therapies, such as replacing damaged tissues or organs.
Mechanism of stem cell function
• Self-Renewal: undergo cell division where one cell remains a stem cell (self-
renewal) and the other cell can differentiate into a specialized cell type.
• Differentiation: undergoes specific signals and processes that lead to specialized
cell type. Influenced by external factors such as growth factors, signaling
molecules and the cellular environment.
• Specialized Cell Type: transformed into a specialized cell type that performs
specific functions in the body. This could be a muscle cell, nerve cell, blood cell,
or any other type depending on the signals and pathways activated during
differentiation.
Factors influencing differentiation
Factor Description Examples
Cell Intrinsic Factors Regulate gene expression and • Gene expression patterns, epigenetic
cell fate. modifications
• Cell cycle state
• Signaling pathways (e.g., Notch, Wnt, BMP)
Extrinsic Factors External signals and cues • Growth factors and cytokines
from the microenvironment • Cell-cell interactions
that influence stem cell • Extracellular matrix composition and stiffness
behavior. • Oxygen levels (hypoxia or normoxia)
• Mechanical forces and biophysical cues
Microenvironmental Characteristics of the tissue- • Tissue-specific microenvironments
Factors specific niche that affect stem • Biophysical cues and topography
cell differentiation. • Metabolic factors and nutrient availability
Developmental Stage The developmental stage and • Embryonic vs. adult developmental stages
and Context overall context that • Tissue-specific developmental requirements
determine cell fate decisions.
Signalling pathways
Stem cell therapy
• A medical therapy that uses
stem cells to repair or replace
damaged tissue or organs.
• Stem cells have unique ability to
develop into various types of
cells in the body.
Applications in regenerative
medicine
• Hematologic Disorders
- Bone Marrow Transplantation: Stem cells are used to
treat diseases like leukemia , lymphoma, and multiple
myeloma. Hematopoietic stem cells (HSCs) from bone
marrow, peripheral blood, or umbilical cord blood are
transplanted to restore healthy blood cell production.
• Neurodegenerative Diseases
- Parkinsons Disease: Stem cells are being explored
to replace damaged neurons in the brain.
Dopaminergic neurons derived from stem cells can
potentially restore motor function.
- Alzheimers Disease: Research focuses on using
stem cells to replace lost neurons and support brain
repair mechanisms, though this application is still
experimental.
• Cardiovascular Diseases
Heart Attack: Stem cells can help repair damaged heart tissue by
differentiating into cardiomyocytes (heart muscle cells). Clinical trials are
investigating their efficacy in improving heart function.
• Musculoskeletal Disorders
-Osteoarthritis: Stem cells can potentially regenerate cartilage and reduce
inflammation in affected joints, offering new treatment avenues for
osteoarthritis.
-Bone Fractures and Spinal Cord Injuries: Stem cells can enhance bone repair
and regeneration. In spinal cord injuries, they may help regenerate nerve
cells and restore function.
• Reproductive Medicine
-Infertility: Stem cells are being studied for their potential to create gametes
(sperm and eggs) for individuals with infertility issues.
Tissue Engineering
• Aims to create functional tissues and organs by harnessing the regenerative
capabilities of stem cells.
• Stem cells are often combined with scaffolds made of biocompatible materials.
• These scaffolds provide a framework that supports cell growth and tissue
formation.
• Components:
1. Cells: can be derived from various sources such as bone marrow, adipose tissue,
or induced pluripotent stem cells (iPSCs)
2. Scaffolds: Biomaterials serve as scaffolds to support the cells and provide a
structure that mimics the extracellular matrix (ECM) of natural tissues.
They degrade over time as the tissue regenerates.
3. Bioreactors: Devices used to provide a controlled environment for the growth
and development of tissues.
Can simulate physiological conditions such as temperature, pH, and mechanical
stress.
Tissue Engineering
Challenges:
• Vascularization: Ensuring adequate blood supply to engineered tissues is crucial
for their survival and integration into the host.
• Integration: Achieving proper integration of engineered tissues with surrounding
tissues and organs.
• Immune Response: Managing immune responses to prevent rejection of
implanted tissues.
• Scale-Up: Scaling up production to meet clinical demand while maintaining
quality and consistency.
Organ Regeneration
• Aimed at advancing our understanding and capabilities in repairing and replacing
damaged or diseased organs.
• Current Research Directions
1. Stem Cell Therapy: focuses on using stem cells to regenerate tissues such as
heart muscle, pancreatic cells for diabetes treatment, and neurons for treating
neurological disorders.
2. Gene Therapy: enhancing expression of growth factors or modifying gene
expression to promote tissue repair.
3. Decellularization and Recellularization
4. Organoids: miniature, simplified versions of organs grown in vitro from stem
cells or organ-specific progenitor cells, used for studying organ development,
disease modeling, and potentially for transplantation in the future.
Ethical Issues
1. Source of Stem Cells:
• Embryonic Stem Cells: involves destruction of embryos, raises ethical concerns
about beginning of human life and moral status of embryos.
• Adult Stem Cells: differentiation potential is more limited.
2. Informed Consent and Privacy
3. Equitable Access and Social Justice
4. Commercialization and Regulation
Ethical Issues
5. Cloning and Genetic Manipulation:
• Somatic Cell Nuclear Transfer (SCNT): Involves transferring a cell nucleus into an
egg cell to generate embryonic stem cells. Raises ethical questions about cloning
and the creation and destruction of embryos.
• Genetic Modification: Techniques like CRISPR/Cas9 enable precise genetic editing,
raises concerns about unintended consequences and ethical considerations
related to altering the human genome.
Legal Issues
• Regulation and Oversight of therapies by regulatory bodies like FDA or EMA.
• Intellectual Property issues involve the patent and proprietary rights associated
with stem cells technologies.
• International Collaboration and Global Standards.
• Litigation and Liability: issues can arise if patients experience adverse effects from
stem cell therapies, especially if therapies were offered outside of regulated
clinical trials or without sufficient evidence of safety and efficacy.
Gene Therapy
• Modification or manipulation of genes within stem cells to treat or prevent
diseases. It can be of various types
• Ex Vivo Approach: Stem cells are harvested from the patient, genetically modified
outside the body to correct the genetic defect using techniques like CRISPR/Cas9,
and then reintroduced into the patient. Aims to treat inherited genetic disorders.
• In Vivo Approach: directly delivered into the body to target specific stem cells in
situ
• Somatic Cell Gene Therapy: Therapeutic genes are transferred into somatic cells
(e.g. bone marrow, blood cells, skin cells). These changes are not inherited by
future generations.
• Germline Gene Therapy: Therapeutic genes are transferred into germ cells (e.g.
eggs and sperm). This approach is heritable but is not currently attempted due to
safety and ethical concerns.
Application of gene therapy
• The first approved gene therapy treated a girl with
Severe Combined Immunodeficiency (ADA-SCID). This
disorder results from a defect in the gene coding for the
enzyme adenosine deaminase (ADA).
• Gene therapy corrected the deficiency by inserting a
functional ADA gene allowing the immune system to
function properly.
• Cystic Fibrosis: In patients with cystic fibrosis, a
defective gene leads to the absence of a protein called
cystic fibrosis transmembrane regulator (CFTR). This
results in respiratory issues.
• In vivo gene therapy using adenovirus vectors can
Bioprinting of stem cells
• Innovative approach that combines stem cell biology with 3D printing
technology to create complex tissue structures for biomedical
applications.
• It is a fascinating and rapidly evolving area of biotechnology. It
involves using 3D printing technologies to create structures with living
cells, including stem cells, with the goal of creating complex tissues
and organs for research, drug testing and eventually for medical
therapies.
Applications and Challenges
Applications:
•Tissue Engineering: Creating tissues for implantation, such as skin, cartilage, or even more
complex organs.
•Disease Modeling: Developing tissues that mimic disease conditions for research and drug
testing.
•Regenerative Medicine: Potentially growing organs or tissues to replace damaged ones.
Challenges:
•Scalability: Producing large, complex tissues or organs that can be used clinically is still a
major challenge.
•Cell Viability: Ensuring that cells remain alive and functional throughout the printing and
maturation processes.
•Vascularization: Creating functional blood vessels within printed tissues
is crucial for nutrient supply and waste removal. Bioprinting vascular
networks is still an active area of research.
THANKYOU
